Edward Mitre Selected Research

ovalbumin-alum

1/2020	Chronic infection with a tissue-invasive helminth attenuates sublethal anaphylaxis and reduces granularity and number of mast cells.
10/2019	Engineered ovalbumin-expressing regulatory T cells protect against anaphylaxis in ovalbumin-sensitized mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward Mitre Research Topics

Disease

27	Infections 03/2022 - 02/2004
8	COVID-19 04/2022 - 10/2020
8	Hypersensitivity (Allergy) 01/2020 - 04/2006
5	Filariasis 01/2020 - 04/2006
5	Anaphylaxis (Anaphylactic Shock) 01/2020 - 10/2014
3	Filarial Elephantiasis (Lymphatic Filariasis) 01/2022 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 11/2011
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 08/2009
3	Inflammation (Inflammations) 01/2018 - 02/2007
2	Parasitic Diseases (Parasitic Disease) 03/2022 - 07/2003
2	Asthma (Bronchial Asthma) 01/2018 - 06/2011
2	Immediate Hypersensitivity 10/2015 - 05/2015
2	Eosinophilia 12/2010 - 01/2006
1	Breakthrough Infections 04/2022
1	Enterobiasis 03/2022
1	Hypothermia 10/2019
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2018
1	Allergic Rhinitis 01/2018
1	Neglected Diseases 01/2017
1	Erythema 10/2014
1	Elephantiasis 08/2013
1	Ocular Onchocerciasis (River Blindness) 08/2013
1	Hepatitis B 06/2011
1	Eczema 06/2011
1	Sepsis (Septicemia) 04/2008
1	Seizures (Absence Seizure) 02/2007
1	Lacunar Stroke 02/2007
1	Vision Disorders (Hemeralopia) 02/2007
1	Hydrocephalus (Hydrocephaly) 02/2007
1	Neurocysticercosis 02/2007

Drug/Important Bio-Agent (IBA)

11	Immunoglobulin E (IgE)IBA 01/2020 - 07/2005
8	AntigensIBA 01/2020 - 02/2004
8	AllergensIBA 10/2019 - 07/2005
7	AntibodiesIBA 04/2022 - 07/2012
6	CytokinesIBA 01/2020 - 01/2006
6	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2008
5	Immunoglobulin G (IgG)IBA 11/2020 - 04/2006
5	VaccinesIBA 09/2013 - 04/2006
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2019
4	Interleukin-4 (Interleukin 4)IBA 12/2010 - 02/2004
3	AnthelminticsIBA 03/2022 - 06/2011
3	Interleukin-5 (Interleukin 5)IBA 12/2015 - 01/2006
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2015 - 01/2006
2	Mebendazole (Anti-Worm)FDA Link 03/2022 - 12/2020
2	Albendazole (Albenza)FDA Link 03/2022 - 12/2020
2	Messenger RNA (mRNA)IBA 07/2021 - 01/2015
2	COVID-19 VaccinesIBA 07/2021 - 06/2021
2	ovalbumin-alumIBA 01/2020 - 10/2019
2	Interleukin-13IBA 12/2015 - 01/2006
2	InterleukinsIBA 02/2010 - 05/2008
1	Nucleocapsid ProteinsIBA 04/2022
1	SARS-CoV-2 spike proteinIBA 07/2021
1	Glycoproteins (Glycoprotein)IBA 06/2021
1	Praziquantel (Biltricide)FDA Link 12/2020
1	oxfendazoleIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	OvalbuminIBA 10/2019
1	Chimeric Antigen ReceptorsIBA 10/2019
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2019
1	Evans Blue (Blue, Evans)FDA Link 01/2019
1	AcidsIBA 01/2018
1	CollagenIBA 01/2018
1	AS 8IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Antiparasitic Agents (Antiparasitics)IBA 01/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2015
1	Histidine DecarboxylaseIBA 01/2015
1	aluminum sulfate (alum)IBA 09/2013
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 06/2011
1	LipopolysaccharidesIBA 04/2008
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008
1	salicylhydroxamic acid (SHAM)IBA 04/2008
1	Prednisone (Sone)FDA LinkGeneric 02/2007
1	Methotrexate (Mexate)FDA LinkGeneric 02/2007
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2007
1	Biomarkers (Surrogate Marker)IBA 07/2003

Therapy/Procedure

5	Therapeutics 01/2020 - 02/2007
2	Injections 01/2020 - 11/2011
1	Microspheres (Microsphere) 10/2020
1	Intraperitoneal Injections 01/2020
1	Subcutaneous Injections 01/2018
1	Immunotherapy 05/2015
1	Aftercare (After-Treatment) 04/2006